A phase 1/2 study of a novel IL-2 cytokine, NKTR-214, and nivolumab in patients with select locally advanced or metastatic solid tumors.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Adi Diab, Nizar M. Tannir, Chantale Bernatchez, Cara L. Haymaker, Salah E Bentebibel, Brendan D. Curti, Michael K.K. Wong, Ivan Gergel, Mary Ann Tagliaferri, Jonathan Zalevsky, Ute Hoch, Sandra Aung, Michael Imperiale, Daniel C. Cho, Scott S. Tykodi, Igor Puzanov, Harriet M. Kluger, Michael E. Hurwitz, Patrick Hwu, Mario Sznol
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2763574253